Page last updated: 2024-09-04

noralfentanil and debrisoquin

noralfentanil has been researched along with debrisoquin in 1 studies

*Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. [MeSH]

*Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. [MeSH]

Compound Research Comparison

Studies
(noralfentanil)
Trials
(noralfentanil)
Recent Studies (post-2010)
(noralfentanil)
Studies
(debrisoquin)
Trials
(debrisoquin)
Recent Studies (post-2010) (debrisoquin)
8018908917

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hendrickx, JJ; Heykants, JJ; Lauwers, W; Lavrijsen, KL; Meuldermans, WE; Van Dyck, DM; Van Houdt, JM; Woestenborghs, RJ1

Other Studies

1 other study(ies) available for noralfentanil and debrisoquin

ArticleYear
Is the metabolism of alfentanil subject to debrisoquine polymorphism? A study using human liver microsomes.
    Anesthesiology, 1988, Volume: 69, Issue:4

    Topics: Alfentanil; Chromatography, High Pressure Liquid; Debrisoquin; Fentanyl; Humans; Hydroxylation; Isoquinolines; Liver; Metabolism, Inborn Errors; Microsomes; Osmolar Concentration

1988